Form EFFECT Inhibikase Therapeutics,

December 6, 2024 6:02 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 5, 2024 4:30 P.M.
Form: S-3
CIK: 0001750149
Company Name: Inhibikase Therapeutics, Inc.
File Number: 333-283307


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings